Eupa Ray
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in ⓘ
-
- Advanced Drug Delivery Systems 5
- Drug Solubulity and Delivery Systems 3
-
- Antimicrobial Peptides and Activities 4
- Co-authors
- Rahul Kumar Verma (19 shared papers)Kalpesh Vaghasiya (12 shared papers)Ankur Sharma (11 shared papers)Om Prakash Katare (4 shared papers)Krishna Jadhav (10 shared papers)Raghuraj Singh (2 shared papers)Rahul Shukla (3 shared papers)Rehan Khan (1 shared paper)
In The Last Decade
Eupa Ray
20 papers receiving 465 citations
Peers
Comparison fields: 5 of 83
- Pharmaceutical Science 103
- Biomaterials 159
- Microbiology 39
- Molecular Medicine 26
- Pulmonary and Respiratory Medicine 109
Countries citing papers authored by Eupa Ray
This map shows the geographic impact of Eupa Ray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eupa Ray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eupa Ray more than expected).
Fields of papers citing papers by Eupa Ray
This network shows the impact of papers produced by Eupa Ray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eupa Ray. The network helps show where Eupa Ray may publish in the future.
Co-authors
The 25 scholars most cited alongside Eupa Ray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 82 | |
| 2 | 2020 | 55 | |
| 3 | 2017 | 41 | |
| 4 | 2020 | 35 | |
| 5 | 2019 | 33 | |
| 6 | 2020 | 33 | |
| 7 | 2017 | 29 | |
| 8 | 2023 | 20 | |
| 9 | 2021 | 19 | |
| 10 | 2024 | 18 | |
| 11 | 2019 | 18 | |
| 12 | 2022 | 17 | |
| 13 | 2018 | 17 | |
| 14 | 2023 | 14 | |
| 15 | 2019 | 11 | |
| 16 | 2024 | 7 | |
| 17 | 2024 | 6 | |
| 18 | 2024 | 5 | |
| 19 | 2024 | 5 | |
| 20 | 2019 | 5 |
About Eupa Ray
Eupa Ray is a scholar working on Pharmaceutical Science, Microbiology, Molecular Medicine, Biomaterials and Pulmonary and Respiratory Medicine, having authored 20 papers that have together received 470 indexed citations. Recurring topics across this work include Inhalation and Respiratory Drug Delivery (9 papers), Advanced Drug Delivery Systems (5 papers), Nanoparticle-Based Drug Delivery (4 papers), Antimicrobial Peptides and Activities (4 papers), Drug Solubulity and Delivery Systems (3 papers), Nanoplatforms for cancer theranostics (3 papers), Microencapsulation and Drying Processes (3 papers) and Antibiotic Resistance in Bacteria (2 papers). The work is most often cited by research in Pharmaceutical Science (103 citations), Biomaterials (159 citations), Microbiology (39 citations), Molecular Medicine (26 citations) and Pulmonary and Respiratory Medicine (109 citations). Eupa Ray has collaborated with scholars based in India, Italy and Nepal. Frequent co-authors include Rahul Kumar Verma, Kalpesh Vaghasiya, Ankur Sharma, Om Prakash Katare, Krishna Jadhav, Raghuraj Singh, Rahul Shukla, Rehan Khan, Preeti Kumari and Balaram Ghosh. Their work appears in journals such as AAPS PharmSciTech, ACS Biomaterials Science & Engineering, Current Protein and Peptide Science, Journal of Materials Chemistry B and International Journal of Biological Macromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.